Matthew Lunning, DO

Matthew Lunning, DOlunning
Assistant Professor, Internal Medicine
Division of Oncology & Hematology

Academic Office mailing address:
UNMC Hematology/Oncology Division
986840 Nebraska Medical Center
Omaha, NE 68198-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax 402-559-6520

Practice Locations:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Nebraska Medicine Village Pointe
111 N. 175th St.
Omaha, NE, 68118 (map)

Hospital Appointments:
Nebraska Medicine

Gustavus Adolphus College, St. Peter, MN, BA (2002)
Des Moines University College of Osteopathic Medicine, Des Moines, IA, MD (2006)
University of Nebraska Medical Center, Omaha, NE, Resident (2009)
University of Nebraska Medical Center, Omaha, NE, Chief Resident (2010)
Memorial Sloan-Kettering Cancer Center, New York, NY, Fellow/Chief Fellow (2013)

Clinical research in rare hematologic malignancies with a focus on early drug development and experimental correlates that leads to enhanced knowledge of how to treat hematologic malignancies. 

Biographical Sketch:
Dr. Lunning is an assistant professor and has been on faculty at UNMC since 2013. He completed his residency at the University of Nebraska Medical Center, including a year as Chief Resident. Dr. Lunning then completed his hematology/oncology fellowship at Memorial Sloan-Kettering Cancer Center located in New York, NY. Dr. Lunning’s expertise is in rare hematologic malignancies including Non-Hodgkin’s Lymphoma and Multiple Myeloma. Dr. Lunning is actively involved in clinical research as well as a member of the graduate student faculty.

Lunning MA. Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray. Oncology (Williston Park, N.Y.). 2015; 0890-9091

Lunning MA, Kutty S, Rome ET, et al.  Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy.   Am J Clin Oncol. 2013 Jul 2. [Epub ahead of print].  PMID: 24192805 

Lunning MA, Moskowitz AJ, Horwitz S.  Strategies for Relapsed Peripheral T-Cell Lymphoma: The Tail That Wags the Curve.  J Clin Oncol.  2013 Jun 1;31(16):1922-7.  PMID: 23630204.

Moskowitz A, Lunning MA, Horwitz SM.  How I treat Peripheral T-cell Lymphoma.  Blood. 2014 Apr 24;123(17):2636-44.

Additional Publications at PubMed.Gov: